Fuchs CS, Doi T, Jang RW-J, et al. KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer. J Clin Oncol. 2017;35 (suppl; abstr 4003).
Een betere prognose voor slokdarmkanker in de nabije toekomst?
apr 2019 | Maag-darm-leveroncologie